- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03313999
Measuring Skin Elasticity in Lymphedema Patients
June 28, 2023 updated by: Dhruv Singhal, Beth Israel Deaconess Medical Center
This protocol will utilize the lymphedema indentometer, or durometer (a novel, noninvasive piece of equipment that measures skin elasticity), to better characterize disease progression in patients with lymphedema.
Beth Israel Deaconess Medical Center patients who undergo treatment of lymphedema will be candidates for this noninvasive test.
This device and the data it generates will help understand the incidence of lymphedema at Beth Israel Deaconess Medical Center compared to national data and the outcomes of surgical treatment of lymphedema.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients evaluated by the Beth Israel Deaconess Medical Center Lymphedema team with a diagnosis of lymphedema OR determined to be at risk of developing Lymphedema in any of their extremities
- Patients must be over 18 years of age
- Patients must be willing and capable to provide informed consent
- Patients must speak English
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Durometer Measurement
All patients participating in the study will receive standard of care treatment for their lymphedema.
As part of the study they will be measured by the durometer in addition to other, standard diagnostics to further characterize their lymphedema progression.
|
The subject will sit down.
The machine will be placed over their extremity/affected region.
They will then be told the machine will be activated.
They may or may not feel the machine touch them.
A small pressure will be applied to the skin surface for 4 seconds.
The computer will record the skin elasticity as change in resistance to compression over time during these 4 seconds.
The entire procedure will take about a minute or less, after which the standard of care visit with the physical therapist will continue.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Durometer Measurement
Time Frame: Enrollment (3 years)
|
Value providing measure for the viscoelastic properties of skin including firmness and mechanical creep.
|
Enrollment (3 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Dhruv Singhal, MD, Beth Israel Deaconess Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 18, 2018
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
October 14, 2017
First Submitted That Met QC Criteria
October 14, 2017
First Posted (Actual)
October 19, 2017
Study Record Updates
Last Update Posted (Actual)
July 3, 2023
Last Update Submitted That Met QC Criteria
June 28, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017P-000378
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data from this study's data repository may be accessed by investigators interested in using the repository for research purposes.
To access the data, investigator(s) will need to obtain Institutional Review Board approval of their protocol and submit their protocol to Dhruv Singhal, MD for review.
Dr. Singhal will review the request for feasibility, scientific validity, and proper regulatory approvals.
Only once the investigator(s) have received written Institutional Review Board approval, written approval from Dr. Singhal, and, if necessary, completed a material transfer agreement will they be given access to data from the repository.
Dr. Singhal is uniquely suited to review requests to use repository data as he is a pioneer in the study and treatment of lymphedema and familiar with all information contained in the database.
IPD Sharing Time Frame
Researchers will only have access to information in the study's database for the duration of their Institutional Review Board approval.
IPD Sharing Access Criteria
After the interested investigator(s) receive Institutional Review Board approval and approval from Dr. Singhal, the study team will securely send the data to the requesting investigator.
Any requesting investigator will receive only durometer measurements, lymphedema characteristics and demographic information from the database.
In all cases the requesting investigator will receive only de-identified data.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymphedema
-
Lymphatica Medtech SATerminatedLymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema ArmSwitzerland
-
Maastricht University Medical CenterRadboud University Medical Center; Erasmus Medical CenterRecruitingLymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema ArmNetherlands
-
Tactile MedicalVanderbilt University Medical CenterActive, not recruitingLymphedema | Lymphedema, Secondary | Lymphedema; Surgical | Lymphedema of Face | Lymphedema Due to RadiationUnited States
-
ThuasneUniversity Hospital, Tours; Delta ConsultantsCompletedLymphedema, Secondary | Lymphedema of Leg | Lymphedema Congenital | Lymphedema PrimaryFrance
-
Odense University HospitalDanish Cancer SocietyActive, not recruitingPathologic Processes | Neoplasms | Skin Diseases | Lymphatic Diseases | Postoperative Complications | Breast Cancer | Breast Diseases | Lymphedema | Breast Neoplasm | Surgery | Secondary Lymphedema | Breast Cancer Lymphedema | Lymphedema, Breast Cancer | Lymphedema of Upper Limb | Lymphedema Arm | Iatrogenic Lymphedema | A... and other conditionsDenmark
-
Swansea Bay University Health BoardSwansea University; Huntleigh Healthcare Ltd; Lymphoedema Wales Clinical NetworkCompleted
-
ResMedLymphatic Solutions, LLCCompletedLymphedema | Lymphedema, Secondary | Lymphedema, Lower Limb | Lymphedema of Leg | Lymphedema PrimaryUnited States
-
University of OttawaMcGill University; Horizon Health Network; University of New Brunswick; New Brunswick...UnknownLymphedema of Upper Limb | Mastectomy Related Lymphedema | Lymphedema of Lower Extremity
-
Odense University HospitalZealand University Hospital; Vejle Hospital; Herlev and Gentofte HospitalRecruitingLymphedema | Breast Cancer Lymphedema | Lymphedema, Breast Cancer | Lymphedema of Upper Limb | Lymphedema, Secondary | Lymphedema Arm | Lymphedema; SurgicalDenmark
-
University Hospital, MontpellierCompletedPrimary Lymphedema Secondary LymphedemaFrance
Clinical Trials on Lymphedema Indentometer
-
Dokuz Eylul UniversityCompletedBreast Cancer Related LymphedemaTurkey
-
Koç UniversityNot yet recruitingLower Extremity Lymphedema
-
Tactile MedicalVanderbilt UniversityCompletedHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck LymphedemaUnited States
-
Ahram Canadian UniversityCompletedBreast Cancer | Breast Cancer FemaleEgypt
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompleted
-
University of VermontCompleted
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedBreast Cancer | LymphedemaUnited States
-
Chongqing University Cancer HospitalRecruitingUterine Cervical Neoplasms | Lymphedema | Endometrial Neoplasms | Treatment EffectivenessChina
-
Ankara City Hospital BilkentEnrolling by invitation
-
M.D. Anderson Cancer CenterActive, not recruiting